+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gastrointestinal Agents Market - Global Forecast 2025-2030- Product Image
Gastrointestinal Agents Market - Global Forecast 2025-2030- Product Image
Sale

Gastrointestinal Agents Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 187 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5977939
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The gastrointestinal agents market faces rapid transformation as pharmaceutical companies adapt to new technologies, evolving patient care models, and shifting global supply chains. As complexity increases, senior decision-makers require timely, actionable insights to remain competitive and deliver effective therapies worldwide.

Market Snapshot: Gastrointestinal Agents Market Growth

The gastrointestinal agents market grew from USD 60.06 billion in 2024 to USD 63.12 billion in 2025. It is expected to continue expanding at a CAGR of 5.00%, reaching USD 80.51 billion by 2030. Segment momentum aligns closely with innovation in digestive therapies, expanded patient populations, and the global focus on preventive and targeted care. Strengthened by digital health advances and regulatory alignment, industry leaders face new opportunities and challenges in every major region.

Scope and Segmentation

This report delivers in-depth coverage across core therapeutic segments, administration routes, distribution channels, and leading geographies. Major pipeline advances, distribution models, and digital health integration shape the market landscape.

  • Product Types: Antacids, anti-diarrheals, anti-emetics, H2 receptor antagonists, laxatives, probiotics and prebiotics, proton pump inhibitors
  • Active Agents: Covers molecules such as aluminum hydroxide, calcium carbonate, bismuth subsalicylate, metoclopramide, esomeprazole, lactobacillus, loperamide, among others
  • Therapeutic Segments: Targets conditions including acid reflux, irritable bowel syndrome, and a variety of digestive disorders
  • Routes of Administration: Oral (tablets, capsules, powders, syrups), intravenous, intramuscular, topical (creams, gels, suppositories)
  • Distribution Channels: Hospital pharmacy, online pharmacy, retail pharmacy
  • Regions: Americas (USA, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including the UK, Germany, UAE, Nigeria), Asia-Pacific (China, India, Japan, Australia, Southeast Asia, and others)
  • Leading Companies: AbbVie Inc., Takeda Pharmaceutical Company Limited, Pfizer Inc., AstraZeneca PLC, Johnson & Johnson, Otsuka Pharmaceutical Co., Ltd., Novartis AG, GlaxoSmithKline plc, Sanofi S.A., Bayer AG
  • Technologies/Trends: Precision medicine, microbiome innovation, digital health, patient-centric delivery systems, and regional manufacturing partnerships

Key Takeaways for Senior Decision-Makers

  • Demand for targeted, patient-centric therapies continues to rise, driven by the shift toward preventive care strategies and improved patient outcomes.
  • Advancement in microbiome research and digital healthcare tools is prompting a move beyond traditional pharmacology toward integrated, technology-enabled treatment paths.
  • Strategic portfolio diversification, including new alliances and regional expansions, enables firms to access growth opportunities and strengthen their market positions.
  • Manufacturers are adapting sourcing and logistics operations to optimize cost structures and maintain supply chain resilience amid evolving global policies.
  • Local regulatory harmonization and healthcare financing models play a pivotal role in accelerating market access for breakthrough therapies, especially in emerging regions.
  • Cross-functional collaboration—spanning clinical development, regulatory, and commercial operations—helps accelerate product launches and maximize portfolio value.

Tariff Impact on Supply Chain and Cost Optimization

Recent tariff policy changes in the United States have complicated sourcing and manufacturing decisions for gastrointestinal agents. Increased duties have led firms to favor regional production and closer supplier relationships, resulting in gradual realignment of logistics, reduced lead times, and enhanced cost optimization. Building robust, localized supply chains is critical for sustained competitiveness as tariff environments evolve.

Methodology & Data Sources

This analysis is grounded in a mixed-methods approach, blending executive interviews with senior industry leaders, secondary review of regulatory and peer-reviewed data, and comprehensive data triangulation. Segment mapping uses standardized classification, ensuring robust and validated results for decision-making.

Why This Report Matters for Business Strategy

  • Provides an actionable foundation for strategic planning across R&D, commercial, and operational teams.
  • Enables data-driven decisions around portfolio management, market entry, and supply chain investments.
  • Helps align organizational priorities with shifting patient needs, regional healthcare models, and evolving regulatory standards.

Conclusion

The gastrointestinal agents market is evolving rapidly as technological innovation and regulatory shifts reshape care delivery. Stakeholders positioned to leverage these trends will be equipped to address emerging opportunities and mitigate future challenges in digestive therapy markets.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of microbiome modulation therapies to treat functional gastrointestinal disorders
5.2. Rising adoption of peptide-based therapeutics for advanced inflammatory bowel disease management
5.3. Integration of digital health solutions and remote monitoring in chronic gastrointestinal disease treatment
5.4. Growing demand for noninvasive diagnostic biomarkers in early detection of gastrointestinal cancers
5.5. Increasing pipeline focus on targeted therapies for celiac disease and gluten sensitivity
5.6. Development of next generation proton pump inhibitors with improved safety profiles
5.7. Surge in clinical research on gut-brain axis modulation for IBS and functional disorders
5.8. Innovations in oral small molecule therapeutics for ulcerative colitis and Crohn’s disease
5.9. Emergence of biosimilar agents competing with originator biologics in GI inflammatory disease
5.10. Adoption of personalized medicine approaches driven by genomic profiling in gastrointestinal care
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Gastrointestinal Agents Market, by Product Type
8.1. Introduction
8.2. Antacids
8.2.1. Aluminum Hydroxide
8.2.2. Calcium Carbonate
8.2.3. Combination Formulations
8.2.4. Magnesium Hydroxide
8.2.5. Sodium Bicarbonate
8.3. Anti Diarrheals
8.3.1. Adsorbents
8.3.1.1. Bismuth Subsalicylate
8.3.1.2. Kaolin Pectin
8.3.2. Opioid Derivatives
8.3.2.1. Diphenoxylate Atropine
8.3.2.2. Loperamide
8.4. Anti Emetics
8.4.1. Dopamine Antagonists
8.4.1.1. Metoclopramide
8.4.1.2. Prochlorperazine
8.4.2. NK1 Receptor Antagonists
8.4.2.1. Aprepitant
8.4.2.2. Fosaprepitant
8.4.3. Serotonin Receptor Antagonists
8.4.3.1. Granisetron
8.4.3.2. Ondansetron
8.4.3.3. Palonosetron
8.5. H2 Receptor Antagonists
8.5.1. Cimetidine
8.5.2. Famotidine
8.5.3. Nizatidine
8.5.4. Ranitidine
8.6. Laxatives
8.6.1. Bulk Forming
8.6.1.1. Methylcellulose
8.6.1.2. Polycarbophil
8.6.1.3. Psyllium
8.6.2. Lubricant
8.6.3. Osmotic
8.6.3.1. Lactulose
8.6.3.2. Polyethylene Glycol
8.6.3.3. Sorbitol
8.6.4. Stimulant
8.6.5. Stool Softeners
8.7. Probiotics & Prebiotics
8.7.1. Prebiotics
8.7.1.1. Fructooligosaccharides
8.7.1.2. Inulin
8.7.2. Probiotics
8.7.2.1. Bifidobacterium
8.7.2.2. Lactobacillus
8.7.2.3. Saccharomyces Boulardii
8.8. Proton Pump Inhibitors
8.8.1. Esomeprazole
8.8.2. Lansoprazole
8.8.3. Omeprazole
8.8.4. Pantoprazole
8.8.5. Rabeprazole
9. Gastrointestinal Agents Market, by Route Of Administration
9.1. Introduction
9.2. Intramuscular
9.3. Intravenous
9.3.1. Bolus Injection
9.3.2. Infusion
9.4. Oral
9.4.1. Capsule
9.4.2. Liquid Syrup
9.4.3. Powder
9.4.4. Tablet
9.5. Topical
9.5.1. Creams
9.5.2. Gels
9.5.3. Suppositories
10. Gastrointestinal Agents Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.4. Retail Pharmacy
11. Americas Gastrointestinal Agents Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa Gastrointestinal Agents Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific Gastrointestinal Agents Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. AbbVie Inc.
14.3.2. Takeda Pharmaceutical Company Limited
14.3.3. Pfizer Inc.
14.3.4. AstraZeneca PLC
14.3.5. Johnson & Johnson
14.3.6. Otsuka Pharmaceutical Co., Ltd.
14.3.7. Novartis AG
14.3.8. GlaxoSmithKline plc
14.3.9. Sanofi S.A.
14.3.10. Bayer AG
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. GASTROINTESTINAL AGENTS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 12. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 14. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GASTROINTESTINAL AGENTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 20. GASTROINTESTINAL AGENTS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 21. GASTROINTESTINAL AGENTS MARKET: RESEARCHAI
FIGURE 22. GASTROINTESTINAL AGENTS MARKET: RESEARCHSTATISTICS
FIGURE 23. GASTROINTESTINAL AGENTS MARKET: RESEARCHCONTACTS
FIGURE 24. GASTROINTESTINAL AGENTS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. GASTROINTESTINAL AGENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTACIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTACIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ALUMINUM HYDROXIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ALUMINUM HYDROXIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY CALCIUM CARBONATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY CALCIUM CARBONATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY COMBINATION FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY COMBINATION FORMULATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY MAGNESIUM HYDROXIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY MAGNESIUM HYDROXIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY SODIUM BICARBONATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY SODIUM BICARBONATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTACIDS, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTACIDS, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI DIARRHEALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI DIARRHEALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ADSORBENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ADSORBENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY BISMUTH SUBSALICYLATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY BISMUTH SUBSALICYLATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY KAOLIN PECTIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY KAOLIN PECTIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ADSORBENTS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ADSORBENTS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY OPIOID DERIVATIVES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY OPIOID DERIVATIVES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DIPHENOXYLATE ATROPINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DIPHENOXYLATE ATROPINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LOPERAMIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LOPERAMIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY OPIOID DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY OPIOID DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI DIARRHEALS, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI DIARRHEALS, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI EMETICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI EMETICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DOPAMINE ANTAGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DOPAMINE ANTAGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY METOCLOPRAMIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY METOCLOPRAMIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PROCHLORPERAZINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PROCHLORPERAZINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DOPAMINE ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DOPAMINE ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY NK1 RECEPTOR ANTAGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY NK1 RECEPTOR ANTAGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY APREPITANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY APREPITANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY FOSAPREPITANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY FOSAPREPITANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY NK1 RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY NK1 RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY SEROTONIN RECEPTOR ANTAGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY SEROTONIN RECEPTOR ANTAGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY GRANISETRON, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY GRANISETRON, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ONDANSETRON, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ONDANSETRON, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PALONOSETRON, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PALONOSETRON, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY SEROTONIN RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY SEROTONIN RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI EMETICS, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI EMETICS, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY CIMETIDINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY CIMETIDINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY FAMOTIDINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY FAMOTIDINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY NIZATIDINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY NIZATIDINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY RANITIDINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY RANITIDINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LAXATIVES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LAXATIVES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY BULK FORMING, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY BULK FORMING, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY METHYLCELLULOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY METHYLCELLULOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY POLYCARBOPHIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY POLYCARBOPHIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PSYLLIUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PSYLLIUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY BULK FORMING, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY BULK FORMING, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LUBRICANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LUBRICANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY OSMOTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY OSMOTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LACTULOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LACTULOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY POLYETHYLENE GLYCOL, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY POLYETHYLENE GLYCOL, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY SORBITOL, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY SORBITOL, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY OSMOTIC, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY OSMOTIC, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY STIMULANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY STIMULANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY STOOL SOFTENERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY STOOL SOFTENERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LAXATIVES, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LAXATIVES, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PROBIOTICS & PREBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PROBIOTICS & PREBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PREBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PREBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY FRUCTOOLIGOSACCHARIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY FRUCTOOLIGOSACCHARIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY INULIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY INULIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PREBIOTICS, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PREBIOTICS, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PROBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY BIFIDOBACTERIUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY BIFIDOBACTERIUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LACTOBACILLUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LACTOBACILLUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY SACCHAROMYCES BOULARDII, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY SACCHAROMYCES BOULARDII, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PROBIOTICS, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PROBIOTICS, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PROBIOTICS & PREBIOTICS, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PROBIOTICS & PREBIOTICS, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PROTON PUMP INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PROTON PUMP INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ESOMEPRAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ESOMEPRAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LANSOPRAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LANSOPRAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY OMEPRAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY OMEPRAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PANTOPRAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PANTOPRAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 149. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY RABEPRAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 150. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY RABEPRAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 151. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2018-2024 (USD MILLION)
TABLE 152. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2025-2030 (USD MILLION)
TABLE 153. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 154. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 155. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 156. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 157. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 158. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 159. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY BOLUS INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 160. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY BOLUS INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 161. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY INFUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 162. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY INFUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 163. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 164. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 165. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 166. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 167. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 168. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 169. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LIQUID SYRUP, BY REGION, 2018-2024 (USD MILLION)
TABLE 170. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LIQUID SYRUP, BY REGION, 2025-2030 (USD MILLION)
TABLE 171. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 172. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 173. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 174. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 175. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 176. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 177. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 178. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 179. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY CREAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 180. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY CREAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 181. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY GELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 182. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY GELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 183. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY SUPPOSITORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 184. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY SUPPOSITORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 185. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 186. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 187. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 190. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 191. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 192. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 193. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 194. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 195. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 196. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 197. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTACIDS, 2018-2024 (USD MILLION)
TABLE 198. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTACIDS, 2025-2030 (USD MILLION)
TABLE 199. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI DIARRHEALS, 2018-2024 (USD MILLION)
TABLE 200. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI DIARRHEALS, 2025-2030 (USD MILLION)
TABLE 201. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY ADSORBENTS, 2018-2024 (USD MILLION)
TABLE 202. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY ADSORBENTS, 2025-2030 (USD MILLION)
TABLE 203. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY OPIOID DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 204. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY OPIOID DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 205. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI EMETICS, 2018-2024 (USD MILLION)
TABLE 206. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI EMETICS, 2025-2030 (USD MILLION)
TABLE 207. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY DOPAMINE ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 208. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY DOPAMINE ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 209. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY NK1 RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 210. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY NK1 RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 211. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY SEROTONIN RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 212. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY SEROTONIN RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 213. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 214. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 215. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY LAXATIVES, 2018-2024 (USD MILLION)
TABLE 216. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY LAXATIVES, 2025-2030 (USD MILLION)
TABLE 217. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY BULK FORMING, 2018-2024 (USD MILLION)
TABLE 218. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY BULK FORMING, 2025-2030 (USD MILLION)
TABLE 219. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY OSMOTIC, 2018-2024 (USD MILLION)
TABLE 220. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY OSMOTIC, 2025-2030 (USD MILLION)
TABLE 221. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY PROBIOTICS & PREBIOTICS, 2018-2024 (USD MILLION)
TABLE 222. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY PROBIOTICS & PREBIOTICS, 2025-2030 (USD MILLION)
TABLE 223. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY PREBIOTICS, 2018-2024 (USD MILLION)
TABLE 224. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY PREBIOTICS, 2025-2030 (USD MILLION)
TABLE 225. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY PROBIOTICS, 2018-2024 (USD MILLION)
TABLE 226. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY PROBIOTICS, 2025-2030 (USD MILLION)
TABLE 227. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2018-2024 (USD MILLION)
TABLE 228. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2025-2030 (USD MILLION)
TABLE 229. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 230. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 231. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 232. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 233. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 234. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 235. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 236. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 237. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 240. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 241. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 242. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 243. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTACIDS, 2018-2024 (USD MILLION)
TABLE 244. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTACIDS, 2025-2030 (USD MILLION)
TABLE 245. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI DIARRHEALS, 2018-2024 (USD MILLION)
TABLE 246. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI DIARRHEALS, 2025-2030 (USD MILLION)
TABLE 247. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY ADSORBENTS, 2018-2024 (USD MILLION)
TABLE 248. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY ADSORBENTS, 2025-2030 (USD MILLION)
TABLE 249. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY OPIOID DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 250. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY OPIOID DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 251. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI EMETICS, 2018-2024 (USD MILLION)
TABLE 252. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI EMETICS, 2025-2030 (USD MILLION)
TABLE 253. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY DOPAMINE ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 254. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY DOPAMINE ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 255. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY NK1 RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 256. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY NK1 RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 257. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY SEROTONIN RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 258. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY SEROTONIN RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 259. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 260. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 261. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY LAXATIVES, 2018-2024 (USD MILLION)
TABLE 262. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY LAXATIVES, 2025-2030 (USD MILLION)
TABLE 263. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY BULK FORMING, 2018-2024 (USD MILLION)
TABLE 264. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY BULK FORMING, 2025-2030 (USD MILLION)
TABLE 265. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY OSMOTIC, 2018-2024 (USD MILLION)
TABLE 266. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY OSMOTIC, 2025-2030 (USD MILLION)
TABLE 267. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY PROBIOTICS & PREBIOTICS, 2018-2024 (USD MILLION)
TABLE 268. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY PROBIOTICS & PREBIOTICS, 2025-2030 (USD MILLION)
TABLE 269. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY PREBIOTICS, 2018-2024 (USD MILLION)
TABLE 270. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY PREBIOTICS, 2025-2030 (USD MILLION)
TABLE 271. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY PROBIOTICS, 2018-2024 (USD MILLION)
TABLE 272. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY PROBIOTICS, 2025-2030 (USD MILLION)
TABLE 273. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2018-2024 (USD MILLION)
TABLE 274. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY PROTON PUMP INHIBITORS, 2025-2030 (USD MILLION)
TABLE 275. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 276. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 277. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 278. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 279. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 280. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 281. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 282. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 283. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 284. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 285. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 286. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 287. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 288. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 289. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTACIDS, 2018-2024 (USD MILLION)
TABLE 290. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTACIDS, 2025-2030 (USD MILLION)
TABLE 291. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI DIARRHEALS, 2018-2024 (USD MILLION)
TABLE 292. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI DIARRHEALS, 2025-2030 (USD MILLION)
TABLE 293. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY ADSORBENTS, 2018-2024 (USD MILLION)
TABLE 294. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY ADSORBENTS, 2025-2030 (USD MILLION)
TABLE 295. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY OPIOID DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 296. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY OPIOID DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 297. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI EMETICS, 2018-2024 (USD MILLION)
TABLE 298. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI EMETICS, 2025-2030 (USD MILLION)
TABLE 299. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY DOPAMINE ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 300. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY DOPAMINE ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 301. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY NK1 RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 302. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY NK1 RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 303. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY SEROTONIN RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 304. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY SEROTONIN RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 305. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2018-2024 (USD MILLION)
TABLE 306. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY H2 RECEPTOR ANTAGONISTS, 2025-2030 (USD MILLION)
TABLE 307. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY LAXATIVES, 2018-2024 (USD MILLION)
TABLE 308. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY LAXATIVES, 2025-2030 (USD MILLION)
TABLE 309. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY BULK FORMING, 2018-2024 (USD MILLION)
TABLE 310. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY BULK FORMING, 2025-2030 (USD MILLION)
TABLE 311. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY OSMOTIC, 2018-2024 (USD MILLION)
TABLE 312. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY OSMOTIC, 2025-2030 (USD MILLION)
TABLE 313. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY PROBIOTICS & PREBIOTICS, 2018-2024 (USD MILLION)
TABLE 314. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY PROBIOTICS & PREBIOTICS, 2025-2030 (USD MILLION)
TABLE 315. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY PREBIOTICS, 2018-2024 (USD MILLION)
TABLE 316. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY PREBIOTICS, 2025-2030 (USD MILLION)
TABLE 317. CANADA GASTROINTE

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Gastrointestinal Agents market report include:
  • AbbVie Inc.
  • Takeda Pharmaceutical Company Limited
  • Pfizer Inc.
  • AstraZeneca PLC
  • Johnson & Johnson
  • Otsuka Pharmaceutical Co., Ltd.
  • Novartis AG
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Bayer AG

Table Information

Report AttributeDetails
No. of Pages187
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 63.12 Billion
Forecasted Market Value ( USD ) by 2030 $ 80.51 Billion
Compound Annual Growth Rate5.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Gastrointestinal Motility Drugs Market - Global Forecast 2025-2030 - Product Image

Gastrointestinal Motility Drugs Market - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Gastrointestinal Diseases Therapeutics Market - Global Forecast 2025-2030 - Product Image

Gastrointestinal Diseases Therapeutics Market - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Gastrointestinal Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Gastrointestinal Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 110 Pages
  • Global
From
Duodenal Ulcer Treatment - Global Strategic Business Report - Product Image

Duodenal Ulcer Treatment - Global Strategic Business Report

  • Report
  • 380 Pages
  • Global
From
Gastrointestinal Therapeutics Market Report by Type, Route of Administration, Application, Distribution Channel, and Region 2025-2033 - Product Image

Gastrointestinal Therapeutics Market Report by Type, Route of Administration, Application, Distribution Channel, and Region 2025-2033

  • Report
  • 133 Pages
  • Global
From

About the Market

The Gastrointestinal Agent market is a subset of the Gastrointestinal Drugs market, which includes drugs used to treat diseases and disorders of the digestive system. These agents are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and antibiotics. Other agents, such as probiotics, are also used to treat gastrointestinal disorders. The Gastrointestinal Agent market is highly competitive, with many companies offering a variety of products. Major players in the market include Pfizer, GlaxoSmithKline, Merck, AstraZeneca, and Novartis. Other companies, such as AbbVie, Allergan, and Takeda, also offer products in this market. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.